Sakai Chemical Industry Co., Ltd.
Notice of Completion of Exercise of the 4th Stock Acquisition Rights and Issuance of New Shares
All stock acquisition rights (4th series) were fully exercised, resulting in issuance of 1,012,600 shares and an increase in the total number of outstanding shares. Total exercise proceeds amounted to approximately 1,999,885,000 yen, and there are no unexercised rights remaining. The funds will be used as M&A standby funds.
Key Figures
- Number of shares issued upon grant of stock acquisition rights: 1,012,600 shares
- Number of stock acquisition rights exercised: 10,126 units
- Total face value of exercised rights: 1,999,885,000 yen
AI要約
Completion of Exercise of Stock Acquisition Rights and Issuance of New Shares
Sakai Chemical Industry Co., Ltd. announced that all of the 4th series stock acquisition rights issued in June 2023 have been fully exercised, and new shares are planned to be issued by October 26, 2026. The number of shares to be delivered is 1,012,600 shares; all 10,126 stock acquisition rights were exercised, representing an exercise ratio of 100.0% against the total issued rights. There are 0 unexercised shares remaining, and funds of 1,999,885,000 yen were raised.
Capital Policy and Use of Funds
All proceeds from the exercise of these stock acquisition rights will be allocated as M&A standby funds to support expansion of growth businesses. Specific M&A targets have not been decided at this time; if funds cannot be allocated within the designated period, they will be considered for use in R&D investment, new business investment, and similar purposes. This is not expected to affect the annual dividend forecast of 160 yen published in August 2026.
Sakai Chemical Industry Co., Ltd.
Company overview · Stock price · Financial data · All IR
